Luteolin is effective in multidrug-resistant (MDR) cancer by inducing apoptosis in MDR cancer cells by generating reactive oxygen species, inhibiting the NF-κB pathway, and depleting the antiapoptotic proteins [79]. This evidence concerns the gene NFKB1 and cancer.